{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T19:46:52Z","timestamp":1789588012769,"version":"build-2803163510"},"reference-count":51,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2021,1,13]],"date-time":"2021-01-13T00:00:00Z","timestamp":1610496000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["PI18\/00276, PI15\/00216"],"award-info":[{"award-number":["PI18\/00276, PI15\/00216"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Lewy body diseases (LBD) including dementia with Lewy bodies (DLB) and Parkinson disease (PD) are characterized by alpha-synuclein pathology. DLB is difficult to diagnose and peripheral biomarkers are urgently needed. Therefore, we analyzed the expression of five alpha-synuclein gene (SNCA) transcripts, SNCAtv1, SNCAtv2, SNCAtv3, SNCA126, and SNCA112, in 45 LBD and control temporal cortex samples and in the blood of 72 DLB, 59 PD, and 54 control subjects. The results revealed overexpression of SNCAtv1 and SNCA112 in DLB, and SNCAtv2 in PD temporal cortices. In DLB blood, diminution of all SNCA transcripts was observed. SNCAtv1 and SNCAtv2 were diminished in PD with disease onset before 70 years. SNCAtv3, driven by its own promoter, showed opposite expression in early DLB and PD, suggesting that its amount may be an early, DLB specific biomarker. Correlation between blood transcript levels and disease duration was positive in DLB and negative in PD, possibly reflecting differences in brain alpha-synuclein aggregation rates associated with differences in disease courses. In conclusion, SNCA transcripts showed a disease-specific increase in the brain and were diminished in blood of LBD patients. SNCAtv3 expression was decreased in early DLB and increased in early PD and could be a biomarker for early DLB diagnosis.<\/jats:p>","DOI":"10.3390\/ijms22020725","type":"journal-article","created":{"date-parts":[[2021,1,13]],"date-time":"2021-01-13T11:52:32Z","timestamp":1610538752000},"page":"725","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Expression Levels of an Alpha-Synuclein Transcript in Blood May Distinguish between Early Dementia with Lewy Bodies and Parkinson\u2019s Disease"],"prefix":"10.3390","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6337-1656","authenticated-orcid":false,"given":"Laura","family":"Marsal-Garc\u00eda","sequence":"first","affiliation":[{"name":"Department of Pathology, Germans Trias i Pujol Research Institute (IGTP), Universitat Aut\u00f2noma de Barcelona (UAB), 08193 Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8458-1209","authenticated-orcid":false,"given":"Aintzane","family":"Urbizu","sequence":"additional","affiliation":[{"name":"Department of Pathology, Germans Trias i Pujol Research Institute (IGTP), Universitat Aut\u00f2noma de Barcelona (UAB), 08193 Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1654-0573","authenticated-orcid":false,"given":"Laura","family":"Arnaldo","sequence":"additional","affiliation":[{"name":"Department of Pathology, Germans Trias i Pujol Research Institute (IGTP), Universitat Aut\u00f2noma de Barcelona (UAB), 08193 Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaume","family":"Campdelacreu","sequence":"additional","affiliation":[{"name":"Servei de Neurologia, Hospital Universitari Bellvitge, 08907 L\u2019Hospitalet de Llobregat, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3084-053X","authenticated-orcid":false,"given":"Dolores","family":"Vilas","sequence":"additional","affiliation":[{"name":"Servei de Neurologia, Hospital Universitari Germans Trias i Pujol, 08916 Badalona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lourdes","family":"Ispierto","sequence":"additional","affiliation":[{"name":"Servei de Neurologia, Hospital Universitari Germans Trias i Pujol, 08916 Badalona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9422-937X","authenticated-orcid":false,"given":"Jordi","family":"Gasc\u00f3n-Bayarri","sequence":"additional","affiliation":[{"name":"Servei de Neurologia, Hospital Universitari Bellvitge, 08907 L\u2019Hospitalet de Llobregat, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ram\u00f3n","family":"Re\u00f1\u00e9","sequence":"additional","affiliation":[{"name":"Servei de Neurologia, Hospital Universitari Bellvitge, 08907 L\u2019Hospitalet de Llobregat, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramiro","family":"\u00c1lvarez","sequence":"additional","affiliation":[{"name":"Servei de Neurologia, Hospital Universitari Germans Trias i Pujol, 08916 Badalona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8905-1514","authenticated-orcid":false,"given":"Katrin","family":"Beyer","sequence":"additional","affiliation":[{"name":"Department of Pathology, Germans Trias i Pujol Research Institute (IGTP), Universitat Aut\u00f2noma de Barcelona (UAB), 08193 Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,1,13]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"6469","DOI":"10.1073\/pnas.95.11.6469","article-title":"\u03b1-Synuclein in filamentous inclusions of Lewy bodies from Parkinson\u2019s disease and dementia with Lewy bodies","volume":"95","author":"Spillantini","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"S85","DOI":"10.1016\/S0197-4580(97)00062-6","article-title":"Diagnostic Criteria for Neuropathologic Assessment of Alzheimer\u2019s Disease","volume":"18","author":"Braak","year":"1997","journal-title":"Neurobiol. Aging"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00401-008-0406-y","article-title":"A critical reappraisal of current staging of Lewy-related pathology in human brain","volume":"116","author":"Jellinger","year":"2008","journal-title":"Acta Neuropathol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.bbadis.2008.07.006","article-title":"A critical evaluation of current staging of \u03b1-synuclein pathology in Lewy body disorders","volume":"1792","author":"Jellinger","year":"2009","journal-title":"Biochim. Biophys. Acta BBA Mol. Basis Dis."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.ncl.2007.03.001","article-title":"Dementia with Lewy Bodies","volume":"25","author":"Ferman","year":"2007","journal-title":"Neurol. Clin."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1212\/WNL.0000000000004058","article-title":"Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium","volume":"89","author":"McKeith","year":"2017","journal-title":"Neurology"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/j.1468-1331.2008.02388.x","article-title":"Differences in clinical course between dementia with Lewy bodies and Alzheimer\u2019s disease","volume":"16","author":"Hanyu","year":"2009","journal-title":"Eur. J. Neurol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"S358","DOI":"10.1002\/mds.21677","article-title":"Cognitive dysfunction and dementia in Parkinson disease","volume":"22","author":"Caballol","year":"2007","journal-title":"Mov. Disord."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s00702-017-1821-9","article-title":"Dementia with Lewy bodies and Parkinson\u2019s disease-dementia: Current concepts and controversies","volume":"125","author":"Jellinger","year":"2018","journal-title":"J. Neural Transm."},{"key":"ref_10","first-page":"216","article-title":"Regional Overlap of Pathologies in Lewy Body Disorders","volume":"76","author":"Planellas","year":"2017","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/nrneurol.2018.23","article-title":"Physiological changes in neurodegeneration\u2014mechanistic insights and clinical utility","volume":"14","author":"Ahmed","year":"2018","journal-title":"Nat. Rev. Neurol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"C3","DOI":"10.1152\/ajpcell.00007.2017","article-title":"Applying fluid biomarkers to Alzheimer\u2019s disease","volume":"313","author":"Zetterberg","year":"2017","journal-title":"Am. J. Physiol. Physiol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.cca.2019.04.078","article-title":"Parkinson\u2019s and Lewy body dementia CSF biomarkers","volume":"495","author":"Parnetti","year":"2019","journal-title":"Clin. Chim. Acta"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"408","DOI":"10.3389\/fnins.2016.00408","article-title":"Alpha-Synuclein Oligomers\u2014Neurotoxic Molecules in Parkinson\u2019s Disease and Other Lewy Body Disorders","volume":"10","author":"Ingelsson","year":"2016","journal-title":"Front. Neurosci."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"525","DOI":"10.12688\/f1000research.10536.1","article-title":"Looking at the recent advances in understanding \u03b1-synuclein and its aggregation through the proteoform prism","volume":"6","author":"Uversky","year":"2017","journal-title":"F1000 Res."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1002\/mds.21007","article-title":"Levels of alpha-synuclein mRNA in sporadic Parkinson disease patients","volume":"21","author":"Lopez","year":"2006","journal-title":"Mov. Disord."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1093\/nar\/gkn084","article-title":"Elevated \u03b1-synuclein mRNA levels in individual UV-laser-microdissected dopaminergic substantia nigra neurons in idiopathic Parkinson\u2019s disease","volume":"36","author":"Schlaudraff","year":"2008","journal-title":"Nucleic Acids Res."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/S0140-6736(04)17104-3","article-title":"Causal relation between \u03b1-synuclein locus duplication as a cause of familial Parkinson\u2019s disease","volume":"364","author":"Bonnet","year":"2004","journal-title":"Lancet"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/S0140-6736(04)17103-1","article-title":"\u03b1-synuclein locus duplication as a cause of familial Parkinson\u2019s disease","volume":"364","author":"Kachergus","year":"2004","journal-title":"Lancet"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1212\/01.WNL.0000127517.33208.F4","article-title":"\u03b1-Synuclein in blood and brain from familial Parkinson disease with SNCA locus triplication","volume":"62","author":"Miller","year":"2004","journal-title":"Neurology"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1002\/mds.27806","article-title":"Longitudinal analyses of cerebrospinal fluid \u03b1-Synuclein in prodromal and early Parkinson\u2019s disease","volume":"34","author":"Mollenhauer","year":"2019","journal-title":"Mov. Disord."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1002\/acn3.644","article-title":"The Parkinson\u2019s progression markers initiative (PPMI)\u2014establishing a PD biomarker cohort","volume":"5","author":"Marek","year":"2018","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"srep02540","DOI":"10.1038\/srep02540","article-title":"A longitudinal study on \u03b1-synuclein in blood plasma as a biomarker for Parkinson\u2019s disease","volume":"3","author":"Foulds","year":"2013","journal-title":"Sci. Rep."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"G\u00e1mez-Valero, A., and Beyer, K. (2018). Alternative Splicing of Alpha- and Beta-Synuclein Genes Plays Differential Roles in Synucleinopathies. Genes, 9.","DOI":"10.3390\/genes9020063"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s12035-012-8330-5","article-title":"Alpha-Synuclein Posttranslational Modification and Alternative Splicing as a Trigger for Neurodegeneration","volume":"47","author":"Beyer","year":"2013","journal-title":"Mol. Neurobiol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ncomms2032","article-title":"Alternative \u03b1-synuclein transcript usage as a convergent mechanism in Parkinson\u2019s disease pathology","volume":"3","author":"Rhinn","year":"2012","journal-title":"Nat. Commun."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00308809","article-title":"Neuropathological stageing of Alzheimer-related changes","volume":"82","author":"Braak","year":"1991","journal-title":"Acta Neuropathol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson\u2019s disease","volume":"24","author":"Braak","year":"2003","journal-title":"Neurobiol. Aging"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1212\/01.wnl.0000187889.17253.b1","article-title":"Diagnosis and management of dementia with Lewy bodies: Third report of the DLB consortium","volume":"65","author":"McKeith","year":"2005","journal-title":"Neurology"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1093\/brain\/awn349","article-title":"Detection of elevated levels of soluble -synuclein oligomers in post-mortem brain extracts from patients with dementia with Lewy bodies","volume":"132","author":"Paleologou","year":"2009","journal-title":"Brain"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1111\/nan.12531","article-title":"Heterogeneity in \u03b1-synuclein subtypes and their expression in cortical brain tissue lysates from Lewy body diseases and Alzheimer\u2019s disease","volume":"45","author":"Vaikath","year":"2019","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/j.1365-2990.2004.00572.x","article-title":"Differential expression of \u03b1-synuclein isoforms in dementia with Lewy bodies","volume":"30","author":"Beyer","year":"2004","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.jmb.2011.05.046","article-title":"Conserved C-Terminal Charge Exerts a Profound Influence on the Aggregation Rate of \u03b1-Synuclein","volume":"411","author":"Levitan","year":"2011","journal-title":"J. Mol. Biol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"8530","DOI":"10.1021\/bi027363r","article-title":"Role of \u03b1-Synuclein Carboxy-Terminus on Fibril Formation in Vitro","volume":"42","author":"Murray","year":"2003","journal-title":"Biochemistry"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"34885","DOI":"10.1074\/jbc.M110.148460","article-title":"Seeded Aggregation and Toxicity of \u03b1-Synuclein and Tau: Cel-lular models of neurodegenerative diseases","volume":"285","author":"Nonaka","year":"2010","journal-title":"J. Biol. Chem."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"324","DOI":"10.5607\/en.2014.23.4.324","article-title":"Protein Transmission, Seeding and Degradation: Key Steps for \u03b1-Synuclein Prion-Like Propagation","volume":"23","author":"Oueslati","year":"2014","journal-title":"Exp. Neurobiol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"3631","DOI":"10.1111\/febs.14587","article-title":"Crucial role of protein oligomerization in the pathogenesis of Alzheimer\u2019s and Parkinson\u2019s diseases","volume":"285","author":"Choi","year":"2018","journal-title":"FEBS J."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/pcn.12462","article-title":"DNA methylation changes atSNCAintron 1 in patients with dementia with Lewy bodies","volume":"71","author":"Funahashi","year":"2017","journal-title":"Psychiatry Clin. Neurosci."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1093\/brain\/awv202","article-title":"Association between \u03b1-synuclein blood transcripts and early, neuroimaging-supported Parkinson\u2019s disease","volume":"138","author":"Locascio","year":"2015","journal-title":"Brain"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1002\/mds.26073","article-title":"Parkinson\u2019s disease correlates with promoter methylation in the \u03b1-synuclein gene","volume":"30","author":"Berge","year":"2015","journal-title":"Mov. Disord."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jns.2013.11.033","article-title":"Hypomethylation of SNCA in blood of patients with sporadic Parkinson\u2019s disease","volume":"337","author":"Ai","year":"2014","journal-title":"J. Neurol. Sci."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Matsumoto, L., Takuma, H., Tamaoka, A., Kurisaki, H., Date, H., Tsuji, S., and Iwata, A. (2010). CpG Demethylation Enhances Alpha-Synuclein Expression and Affects the Pathogenesis of Parkinson\u2019s Disease. PLoS ONE, 5.","DOI":"10.1371\/journal.pone.0015522"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1002\/acn3.50944","article-title":"\u03b1-Synuclein in blood cells differentiates Parkinson\u2019s disease from healthy controls","volume":"6","author":"Elhadi","year":"2019","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s00441-017-2733-6","article-title":"Propagation of alpha-synuclein pathology from the olfactory bulb: Possible role in the pathogenesis of dementia with Lewy bodies","volume":"373","author":"Cersosimo","year":"2017","journal-title":"Cell Tissue Res."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1136\/jnnp.55.3.181","article-title":"Accuracy of clinical diagnosis of idiopathic Parkinson\u2019s disease: A clinico-pathological study of 100 cases","volume":"55","author":"Hughes","year":"1992","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1159\/000112832","article-title":"Red Blood Cells Are the Major Source of Alpha-Synuclein in Blood","volume":"5","author":"Barbour","year":"2008","journal-title":"Neurodegener. Dis."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1097\/NEN.0b013e3181c7e32f","article-title":"Effects of Antemortem and Postmortem Variables on Human Brain mRNA Quality: A BrainNet Europe Study","volume":"69","author":"Durrenberger","year":"2010","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"3724","DOI":"10.1093\/brain\/awq275","article-title":"The decrease of \u03b2-synuclein in cortical brain areas defines a molecular subgroup of dementia with Lewy bodies","volume":"133","author":"Beyer","year":"2010","journal-title":"Brain"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1096\/fj.07-9348com","article-title":"Genetic variability in the SNCA gene influences \u03b1-synuclein levels in the blood and brain","volume":"22","author":"Fuchs","year":"2008","journal-title":"FASEB J."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"research0034-1","DOI":"10.1186\/gb-2002-3-7-research0034","article-title":"Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes","volume":"3","author":"Vandesompele","year":"2002","journal-title":"Genome Biol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.gpb.2015.11.004","article-title":"EDISON-WMW: Exact Dynamic Programing Solution of the Wilcoxon\u2013Mann\u2013Whitney Test","volume":"14","author":"Marx","year":"2016","journal-title":"Genom. Proteom. Bioinform."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/2\/725\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T05:10:29Z","timestamp":1760159429000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/2\/725"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,13]]},"references-count":51,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2021,1]]}},"alternative-id":["ijms22020725"],"URL":"https:\/\/doi.org\/10.3390\/ijms22020725","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,13]]}}}